Challenges and Opportunities in German E-cigarette Market

Events by 2FIRSTS.ai
Sep.16.2023
Challenges and Opportunities in German E-cigarette Market
German distributor E-ZIGARETTEN-HANDEL.DE revealed challenges in the German e-cigarette market due to regulations and increased taxes.

At the Dortmund Tobacco Expo on September 15th, the representative of German distributor E-ZIGARETTEN-HANDEL.DE shared some insights about their business with 2FIRSTS. They primarily focus on the markets in Germany and Austria, with their most popular brands being ELFBAR, VOOPOO, and ELFLIO, among others.

 

When discussing the current state of the German market, the spokesperson mentioned that since Germany introduced a tax on e-liquids, many smaller-scale distributors have ceased operations within three months. Additionally, several brands have also faced certain limitations.

 

In addition, the spokesperson also pointed out that the compliance procedures in the German e-cigarette market are relatively cumbersome and require more time. He illustrated this with two specific examples, namely that the packaging and compliance information of e-cigarette products in Germany need to be strictly regulated, thus requiring brand manufacturers to invest more costs in this area. Furthermore, if a product has "warning labels" affixed in Austria, it cannot be directly sold in Germany and needs to be reworked to comply with German regulatory requirements.

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Related Topics